Jump to content

Drug-induced intracranial hypertension

From Wikipedia, the free encyclopedia


Drug-induced intracranial hypertension (DIIH) or medication-induced intracranial hypertension is a condition of higher than normal intracranial pressure (raised pressure inside of the skull) with the main cause being a drug.[1] This condition is similar to idiopathic intracranial hypertension, however the etiology in this instance is a drug.[2] The most frequent symptoms are headaches, pulsatile tinnitus, diplopia, and impairment of visual acuity.[1][3] The only observable signs of the condition may be papilledema and bilateral sixth cranial nerve (abducens) palsies.[3]

See also[edit]

References[edit]

  1. ^ a b Tan, Marcus G.; Worley, Brandon; Kim, Whan B.; ten Hove, Martin; Beecker, Jennifer (April 2020). "Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes". American Journal of Clinical Dermatology. 21 (2): 163–172. doi:10.1007/s40257-019-00485-z. ISSN 1175-0561.
  2. ^ Friedman, Deborah I. (2005-02-01). "Medication-Induced Intracranial Hypertension in Dermatology". American Journal of Clinical Dermatology. 6 (1): 29–37. doi:10.2165/00128071-200506010-00004. ISSN 1179-1888.
  3. ^ a b Jain, Kewal K. (2021), Jain, Kewal K. (ed.), "Drug-Induced Intracranial Hypertension", Drug-induced Neurological Disorders, Cham: Springer International Publishing, pp. 169–180, doi:10.1007/978-3-030-73503-6_12, ISBN 978-3-030-73503-6, retrieved 2024-06-23